PI
REGN icon

PEAK6 Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

PEAK6 Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.99M Sell
3,800
-1,700
-31% -$1.89M 0.01% 1077
2024
Q2 		$5.78M Sell
5,500
-10,800
-66% -$10.5M 0.02% 778
2024
Q1 		$15.7M Buy
16,300
+1,500
+10% +$1.43M 0.04% 357
2023
Q4 		$13M Sell
14,800
-11,700
-44% -$9.63M 0.05% 375
2023
Q3 		$21.8M Sell
26,500
-3,200
-11% -$2.51M 0.1% 164
2023
Q2 		$21.3M Buy
29,700
+8,600
+41% +$6.63M 0.1% 175
2023
Q1 		$17.3M Buy
21,100
+9,300
+79% +$7.01M 0.08% 218
2022
Q4 		$8.51M Sell
11,800
-27,300
-70% -$20.1M 0.05% 444
2022
Q3 		$26.9M Sell
39,100
-60,200
-61% -$37.9M 0.11% 159
2022
Q2 		$62.5M Buy
99,300
+28,900
+41% +$18.8M 0.12% 127
2022
Q1 		$49.2M Sell
70,400
-11,400
-14% -$7.21M 0.1% 164
2021
Q4 		$51.7M Buy
81,800
+25,300
+45% +$15.6M 0.11% 171
2021
Q3 		$34.2M Sell
56,500
-6,162
-10% -$3.83M 0.08% 224
2021
Q2 		$38.4M Buy
62,662
+47,662
+318% +$24.1M 0.09% 197
2021
Q1 		$7.1M Sell
15,000
-84,100
-85% -$40.9M 0.02% 819
2020
Q4 		$47.9M Buy
99,100
+27,600
+39% +$14.9M 0.1% 175
2020
Q3 		$40M Sell
71,500
-104,500
-59% -$63.4M 0.1% 176
2020
Q2 		$110M Sell
176,000
-5,700
-3% -$3.24M 0.38% 40
2020
Q1 		$88.7M Buy
181,700
+146,500
+416% +$60.4M 0.52% 28
2019
Q4 		$13.2M Buy
35,200
+15,500
+79% +$5.21M 0.07% 298
2019
Q3 		$5.46M Sell
19,700
-2,100
-10% -$621K 0.03% 631
2019
Q2 		$6.82M Sell
21,800
-2,700
-11% -$899K 0.05% 530
2019
Q1 		$10.1M Buy
24,500
+18,200
+289% +$7.49M 0.06% 370
2018
Q4 		$2.35M Sell
6,300
-55,000
-90% -$20.1M 0.01% 1122
2018
Q3 		$24.8M Buy
+61,300
New +$23.3M 0.11% 179

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PEAK6 Investments's REGN Position: Q3 2024 in Review

PEAK6 Investments held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2024 at 2 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #3314.

PEAK6 Investments first reported a position in REGN in Q4 2018 and has held it in 20 quarters since. The position peaked at $12.5M in Q1 2021. 1,389 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

  • PEAK6 Investments held 2 shares of Regeneron Pharmaceuticals worth $1.73K as of Q3 2024.
  • PEAK6 Investments left its Regeneron Pharmaceuticals share count unchanged in Q3 2024.
  • Regeneron Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3314 holding.
  • PEAK6 Investments first reported a position in Regeneron Pharmaceuticals in Q4 2018 and has held it in 20 quarters since.
  • PEAK6 Investments's Regeneron Pharmaceuticals position peaked at $12.5M in Q1 2021.
  • 1,389 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.